⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for arginine

Every month we try and update this database with for arginine cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Immunonutrition Supplementation in Head and Neck Cancer Patients Undergoing Cancer Treatment StudyNCT05526040
Head and Neck C...
Immunonutrient-...
Standard medica...
18 Years - University of Malaya
The HepatoPancreaticoBiliary Resection Arginine Immunomodulation (PRIMe) TrialNCT04549662
Hepatopancreati...
Surgery
Active A
Active B
Lipid bolus
Placebo oil
18 Years - Sunnybrook Health Sciences Centre
PH 2 ADI-PEG 20 Study in Non-Hodgkin's Lymphoma Subjects Who Have Failed Prior Systemic TherapyNCT01910025
Non-Hodgkin's L...
ADI-PEG 20
20 Years - Polaris Group
ADI-PEG 20 Plus Radiotherapy and Temozolomide in Subjects With Glioblastoma MultiformeNCT04587830
Glioblastoma Mu...
ADI-PEG20
Temozolomide
20 Years - 75 YearsPolaris Group
The HepatoPancreaticoBiliary Resection Arginine Immunomodulation (PRIMe) TrialNCT04549662
Hepatopancreati...
Surgery
Active A
Active B
Lipid bolus
Placebo oil
18 Years - Sunnybrook Health Sciences Centre
Ph 1 Trial of ADI-PEG 20 Plus Docetaxel in Solid Tumors With Emphasis on Prostate Cancer and Non-Small Cell Lung CancerNCT01497925
Solid Tumors
Prostate Cancer
ADI-PEG 20
18 Years - Polaris Group
Immunonutrition Supplementation in Head and Neck Cancer Patients Undergoing Cancer Treatment StudyNCT05526040
Head and Neck C...
Immunonutrient-...
Standard medica...
18 Years - University of Malaya
Study of ADI-PEG 20 in Patients With Advanced MelanomaNCT00520299
Metastatic Mela...
Skin Cancer
Neoplasm
ADI PEG 20
18 Years - Ludwig Institute for Cancer Research
A Study Evaluating the Safety and Activity of Pegylated Recombinant Human Arginase (BCT-100)NCT03455140
Cancer
Pediatric Solid...
Pediatric AML
Pediatric ALL
PEG- BCT-100
1 Year - 25 YearsUniversity of Birmingham
Clinical Benefits of Preoperative Nutrition Support With Enteral Immune-enhancing Formulas in Surgical OncologyNCT01032512
CANCER
SUPPORTAN + GLU...
NO PREOPERATIVE...
- 80 YearsUniversity of Chile
Study of ADI-PEG 20 in Patients With Advanced MelanomaNCT00520299
Metastatic Mela...
Skin Cancer
Neoplasm
ADI PEG 20
18 Years - Ludwig Institute for Cancer Research
Arginine Feeding: a Novel Strategy to Improve Protein Metabolism in Cancer and the Response to SurgeryNCT00497380
Protein Metabol...
Arginine
30 Years - Texas A&M University
Supplementation of L-arginine in Patients With Non-resectable Brain MetastasesNCT02844387
Unresectable Mu...
L-arginine hydr...
Placebo
18 Years - Instituto de Oncología Ángel H. Roffo
Ph 1-2 Study ADI-PEG 20 Plus FOLFOX in Subjects With Advanced GI Malignancies Focusing on Hepatocellular CarcinomaNCT02102022
Advanced Gastro...
Hepatocellular ...
Gastric Cancer
Colorectal Canc...
ADI-PEG 20 plus...
18 Years - Polaris Group
PH 2 ADI-PEG 20 Study in Non-Hodgkin's Lymphoma Subjects Who Have Failed Prior Systemic TherapyNCT01910025
Non-Hodgkin's L...
ADI-PEG 20
20 Years - Polaris Group
Ph 1 Trial of ADI PEG 20 Plus Sorafenib to Treat Patients With Liver CancerNCT02101593
Hepatocellular ...
ADI-PEG 20
18 Years - Polaris Group
Ph 1B Trial With ADI-PEG 20 Plus Nab-Paclitaxel and Gemcitabine in Subjects With Pancreatic CancerNCT02101580
Advanced Pancre...
ADI-PEG 20
18 Years - Polaris Group
Study of ADI-PEG 20 or Placebo Plus Gem and Doc in Previously Treated Subjects With Leiomyosarcoma (ARGSARC)NCT05712694
Soft Tissue Sar...
ADI PEG20
Placebo
18 Years - 99 YearsPolaris Group
ADI-PEG 20 Plus Radiotherapy and Temozolomide in Subjects With Glioblastoma MultiformeNCT04587830
Glioblastoma Mu...
ADI-PEG20
Temozolomide
20 Years - 75 YearsPolaris Group
PH 2 ADI-PEG 20 Acute Myeloid LeukemiaNCT01910012
Acute Myeloid L...
ADI-PEG 20
18 Years - Polaris Group
Arginine Feeding: a Novel Strategy to Improve Protein Metabolism in Cancer and the Response to SurgeryNCT00497380
Protein Metabol...
Arginine
30 Years - Texas A&M University
Ph 1-2 Study ADI-PEG 20 Plus FOLFOX in Subjects With Advanced GI Malignancies Focusing on Hepatocellular CarcinomaNCT02102022
Advanced Gastro...
Hepatocellular ...
Gastric Cancer
Colorectal Canc...
ADI-PEG 20 plus...
18 Years - Polaris Group
Ph 3 ADI-PEG 20 Versus Placebo in Subjects With Advanced Hepatocellular Carcinoma Who Have Failed Prior Systemic TherapyNCT01287585
Hepatocellular ...
ADI-PEG 20 (arg...
Placebo
Best Supportive...
18 Years - Polaris Group
Immunonutrition Supplementation in Head and Neck Cancer Patients Undergoing Cancer Treatment StudyNCT05526040
Head and Neck C...
Immunonutrient-...
Standard medica...
18 Years - University of Malaya
A Study Evaluating the Safety and Activity of Pegylated Recombinant Human Arginase (BCT-100)NCT03455140
Cancer
Pediatric Solid...
Pediatric AML
Pediatric ALL
PEG- BCT-100
1 Year - 25 YearsUniversity of Birmingham
Ph 1 Trial of ADI-PEG 20 Plus Cisplatin in Patients With Metastatic MelanomaNCT01665183
Cutaneous Melan...
ADI-PEG 20
18 Years - Polaris Group
Ph 1 Trial of ADI-PEG 20 Plus Docetaxel in Solid Tumors With Emphasis on Prostate Cancer and Non-Small Cell Lung CancerNCT01497925
Solid Tumors
Prostate Cancer
ADI-PEG 20
18 Years - Polaris Group
Ph 3 ADI-PEG 20 Versus Placebo in Subjects With Advanced Hepatocellular Carcinoma Who Have Failed Prior Systemic TherapyNCT01287585
Hepatocellular ...
ADI-PEG 20 (arg...
Placebo
Best Supportive...
18 Years - Polaris Group
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: